Revelation Partners is a Switzerland-based investor that has participated in late-stage healthcare funding. The firm co-led a €120 million Series C round for Nouscom, a Swiss cancer immunotherapy company, in 2021. No further public information about the firm's strategy, portfolio, or team is available.
Profile auto-generated from public sources — details unverified.